Iranian Journal of Veterinary Surgery

Iranian Journal of Veterinary Surgery

Functional Recovery in Spinal Cord-Injured Rats Treated with Melatonin-Chitosan Hydrogel: A Behavioral Study

Document Type : Original Article

Authors
Fariborz Afroozi 1
Ahmad Asghari 1
Gholamreza Abedi 1
Pejman Mortazavi 2
Hesam Uddin Hoseinzadeh 3
1 Department of Veterinary Clinical Sciences, SR.C., Islamic Azad University, Tehran, Iran.
2 Department of Pathobiology, SR.C., Islamic Azad University, Tehran, Iran.
3 Department of Clinical Sciences, Karaj Branch, Islamic Azad University, Karaj, Iran.
10.30500/ivsa.2025.521768.1445
Abstract
Spinal cord injury (SCI) leads to the loss of neural and glial cells, along with significant neuroinflammation. Hydrogel formulation, designed for sustained melatonin release, has shown promising therapeutic potentials. In this study, SCI was induced in rats via T9 vertebral contusion, and the CH/Mel hydrogel was characterized using SEM and FTIR. SEM imaging confirmed the hydrogel porous structure. Twenty male Wistar rats were divided into five groups (n = 4 per group): SHAM group with no surgery. SCI group: SCI-induced rats were treated locally with 100 µl CH hydrogel as a control group. SCI/50 group: SCI-induced rats were treated locally with 100 µl CH hydrogel containing 50 mg/kg melatonin. SCI/100 group: SCI-induced rats were treated locally with 100 µl CH hydrogel containing 100 mg/kg melatonin. SCI/200 group: SCI-induced rats were treated locally with 100 µl CH hydrogel containing 200 mg/kg melatonin. In vitro tests revealed that 25 mg/ml CH/Mel hydrogel significantly boosted U87 cell viability after 24 hours. Behavioral assessments demonstrated that CH/Mel hydrogel treatment markedly improved functional recovery in SCI rats, supporting its therapeutic efficacy. The use of CH/Mel hydrogel was shown to effectively enhance the recovery of rats with SCI indicated by improving behavioral assessments.
Keywords
Spinal cord injury
Melatonin
Chitosan
Behavioral assessment
Subjects
  1. Freyermuth-Trujillo X, Segura-Uribe JJ, Salgado-Ceballos H, Orozco-Barrios CE, Coyoy-Salgado A. Inflammation: a target for treatment in spinal cord injury. Cells. 2022; 11(17): 2692. doi: 10.3390/cells11172692.
  2. Shank CD, Walters BC, Hadley MN. Management of acute traumatic spinal cord injuries. Handbook of Clinical Neurology. 2017; 140: 275-298. doi: 10.1016/B978-0-444-63600-3.00015-5.
  3. Hayta, E, Elden H. Acute spinal cord injury: a review of pathophysiology and potential of non-steroidal anti-inflammatory drugs for pharmacological intervention. Journal of Chemical Neuroanatomy. 2018; 87: 25-31. doi: 10.1016/j.jchemneu.2017.08.001
  4. Patek M, Stewart M. Spinal cord injury. Anaesthesia and Intensive Care. 2020; 21(8): 411-416. doi: 10.1016/j.mpaic.2023.04.006
  5. Naseem M, Parvez S. Role of melatonin in traumatic brain injury and spinal cord injury. Scientific World Journal. 2014; 586270. doi: 10.1155/2014/586270
  6. Lis A, Szarek D, Laska J. Strategie inzynierii biomateriałów dla regeneracji rdzenia kregowego: aktualny stan wiedzy [Biomaterials engineering strategies for spinal cord regeneration: state of the art]. Polimery w Medycynie. 2013; 43(2): 59–80.
  7. Mao L, Wang H, Qiao L, Wang X. Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice. Mediators of Inflammation. 2010; 238321. doi: 10.1155/2010/238321
  8. Ritz MF, Hausmann ON. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Research. 2008; 1203: 177-188. doi: 10.1016/j.brainres.2008.01.091
  9. Paterniti I, Genovese T, Crisafulli C, Mazzon E, Di Paola R, Galuppo M, Bramanti P, Cuzzocrea S. Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma. Naunyn-Schmiedeberg's Archives of Pharmacology. 2009; 380(2): 179-192. doi: 10.1007/s00210-009-0414-z
  10. Tukmachev D, Forostyak S, Koci Z, Zaviskova K, Vackova I, Vyborny K, Sandvig I, Sandvig A, Medberry CJ, Badylak SF, Sykova E, Kubinova S. Injectable extracellular matrix hydrogels as scaffolds for spinal cord injury repair. Tissue Engineering. Part A. 2016; 22(3-4): 306–317. doi: 10.1089/ten.TEA.2015.0422
  11. Lin PH, Dong Q, Chew SY. Injectable hydrogels in stroke and spinal cord injury treatment: a review on hydrogel materials, cell–matrix interactions and glial involvement. Materials Advances. 2021; 2(8): 2561-2583. doi: 10.1039/d0ma00732c
  12. Wang Y, Wang Z, Lu W, Hu Y. Review on chitosan-based antibacterial hydrogels: preparation, mechanisms, and applications. International Journal of Biological Macromolecules. 2024; 255: 128080. doi: 10.1016/j.ijbiomac.2023.128080
  13. Pakulska MM, Ballios BG, Shoichet MS. Injectable hydrogels for central nervous system therapy. Biomedical Materials. 2012; 7(2): 024101. doi: 10.1088/1748-6041/7/2/024101
  14. Shariatinia Z, Jalali AM. Chitosan-based hydrogels: preparation, properties and applications. International Journal of Biological Macromolecules. 2018; 115: 194–220. doi: 10.1016/j.ijbiomac.2018.04.034
  15. Aranaz I, Alcántara AR, Civera MC, Arias C, Elorza B, Heras Caballero A, Acosta N. Chitosan: an overview of its properties and applications. Polymers. 2021; 13(19): 3256. doi: 10.3390/polym13193256
  16. Khattak S, Wahid F, Liu LP, Jia SR, Chu LQ, Xie YY, Li ZX, Zhong C. Applications of cellulose and chitin/chitosan derivatives and composites as antibacterial materials: current state and perspectives. Applied Microbiology and Biotechnology. 2019; 103(5): 1989-2006. doi: 10.1007/s00253-018-09602-0
  17. Hong Y, Palaksha KJ, Park K, Park S, Kim HD, Reiter RJ, Chang KT. Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury. Journal of Pineal Research. 49(3): 201–209. doi: 10.1111/j.1600-079X.2010.00786.x
  18. Xie L, Wu H, Huang X, Yu T. Melatonin, a natural antioxidant therapy in spinal cord injury. Frontiers in Cell and Developmental Biology. 2023; 11: 1218553. doi: 10.3389/fcell.2023.1218553
  19. Kaczmarek-Szczepańska B, Pin JM, Zasada L, Sonne MM, Reiter RJ, Slominski AT, Steinbrink K, Kleszczyński, K. Assessment of melatonin-cultured collagen/chitosan scaffolds cross-linked by a glyoxal solution as biomaterials for wound healing. Antioxidants. 2022; 11(3): 570. doi: 10.3390/antiox11030570
  20. Valencia C, Valencia CH, Zuluaga F, Valencia ME, Mina JH, Grande-Tovar CD. Synthesis and application of scaffolds of chitosan-graphene oxide by the freeze-drying method for tissue regeneration. Molecules. 2018; 23(10): 2651. doi: 10.3390/molecules23102651
  21. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. Journal of Neurotrauma. 1995; 12(1): 1-21. doi: 10.1089/neu.1995.12.1
  22. Gholami M, Gilanpour H, Sadeghinezhad J, Asghari A. Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2021; 29(2): 255–265. doi: 10.1007/s40199-021-00399-4
  23. Cai M, Chen L, Wang T, Liang Y, Zhao J, Zhang X, Li Z, Wu H. Hydrogel scaffolds in the treatment of spinal cord injury: a review. Frontiers in Neuroscience. 2023; 17: 1211066. doi: 10.3389/fnins.2023.1211066
  24. Karsy M, Hawryluk G. Modern medical management of spinal cord injury. Current Neurology and Neuroscience Reports. 2019; 19(9): 65. doi: 10.1007/s11910-019-0984-1
  25. Ashammakhi N, Kim H-J, Ehsanipour A, Bierman RD, Kaarela O, Xue C, Khademhosseini A, Seidlits SK. Regenerative therapies for spinal cord injury. Tissue Engineering. Part B, Reviews. 2019; 25(6): 471–491. doi: 10.1089/ten.TEB.2019.0182
  26. Cai M, Chen L, Wang T, Liang Y, Zhao J, Zhang X, Li Z, Wu H. Hydrogel scaffolds in the treatment of spinal cord injury: a review. Frontiers in Neuroscience. 2023; 31:1211066. doi: 10.3389/fnins.2023.1211066
  27. Liu T, Zhang Q, Li H, Cui X, Qi Z, Yang X. An injectable, self-healing, electroconductive hydrogel loaded with neural stem cells and donepezil for enhancing local therapy effect of spinal cord injury. Journal of Biological Engineering. 2023; 17(1): 48. doi: 10.1186/s13036-023-00368-2
  28. Luo Y, Fan L, Liu C, Wen H, Wang S, Guan P, Chen D, Ning C, Zhou L, Tan G. An injectable, self-healing, electroconductive extracellular matrix-based hydrogel for enhancing tissue repair after traumatic spinal cord injury. Bioactive Materials. 2021; 7: 98-111. doi: 10.1016/j.bioactmat.2021.05.039
  29. Li Y, Guo Y, Fan Y, Tian H, Li K, Mei X. Melatonin enhances autophagy and reduces apoptosis to promote locomotor recovery in spinal cord injury via the pi3k/akt/mtor signaling pathway. Neurochemical Research. 2019; 44(8): 2007-2019. doi: 10.1007/s11064-019-02838-w
  30. Gao K, Niu J, Dang X. Neuroprotection of melatonin on spinal cord injury by activating autophagy and inhibiting apoptosis via SIRT1/AMPK signaling pathway. Biotechnology Letters. 2020; 42(10): 2059-2069. doi: 10.1007/s10529-020-02939-5
Iranian Journal of Veterinary Surgery
Volume 20, Issue 2 - Serial Number 43
October 2025
Pages 151-158

  • Receive Date 06 May 2025
  • Revise Date 28 June 2025
  • Accept Date 12 July 2025
  • First Publish Date 12 July 2025